🇺🇸 FDA
Patent

US 10995087

Crystal form of URAT1 inhibitor, and preparation method therefor

granted A61KA61K31/4196A61P

Quick answer

US patent 10995087 (Crystal form of URAT1 inhibitor, and preparation method therefor) held by Medshine Discovery Inc. expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Medshine Discovery Inc.
Grant date
Tue May 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/4196, A61P, A61P19/06